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A novel asymmetric-axle-supported chiral NeO amide was synthesized and used in catalytic enantio-
selective hydrosilylation of N-aryl ketimines with HSiCl3 at room temperature instead of the typical
20 C. High conversion yield and high enantioselectivity up to 96% were observed.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Enantioselective hydrosilylation of C]N with HSiCl3 has been
proven to be a powerful method for producing chiral amines.1
Three major families of organocatalysts have been developed
(Fig. 1): N-formyl derivative (1),1b,2 picolinamide analog (2),3 and
pyridyl-oxazoline (3).1c,4 When classiﬁed by catalyst structural
characteristics, an axial ligand, such as a BINAM derivative (4),5
a polymer-supported ligand (5),6 a C2-asymmetric ligand (6),7
and others8 were also found to have good enantioselectivities. All
reactions reported were performed at low temperatures (e.g.,
20 C). Until now, the catalysts with NeO structure have rarely
reported in the enantioselective hydrosilylation of C]N with
HSiCl3. In our recent study, a biscarboline ester with NeO structure
(7)9 was synthesized and used in asymmetric additions of tri-
chlorosilanes to aldehydes to give up corresponding products with
up to 99% ee. For the polymer-supported and axial catalyst struc-
tures, we have designed and synthesized a series of asymmetric-
axle-supported ligands, such as 8, and investigated theirmail addresses: hjzhu@mail.-
r Ltd. Open access under CC BY license.application to hydrosilylation of ketimines with trichlorosilane at
room temperature. Catalyst 8 is different from ligand 6, in which
two chiral active moieties are connected via a ﬂexible linear linkage
such that no axial conformer can form in solution. While the CeC
bond connections in 8 forms an axial asymmetric space, it was
anticipated only one chiral molecular residue (e.g., the moiety
highlighted in the blue box) catalyzes the reactions.2. Results and discussion
The synthetic route to 8 is illustrated in Scheme 1. Compound 9
was synthesized as described in our previous study.9 After hydro-
lysis of 9, the intermediate 10, which was obtained in a yield of 93%
was condensed with (1S,2R)-(þ)-2-amino-1,2-diphenylethanol to
form 11 in a yield of 95%, which is oxidized to 8 using 8 equiv of
peroxide-urea and TFA at room temperature for 2 days. One major
epimer product was obtained with a single step yield of 48% after
column chromatography. Bis-NeO products were obtained in a low
yield (less than 10%).
Stereochemistry of the major structure was determined using
a widely accepted quantum theory.10 Conformational searches
were performed by ﬁrst using a MMFF94S force ﬁeld. All stable
conformations were then optimized at the B3LYP/6-31G(d) level.
Single point energy (SPE) was computed for the low energy con-
formers (0e2.5 kcal/mol) at the B3LYP/6-311G(d) level. The catalyst









W. Pan et al. / Tetrahedron 69 (2013) 7253e72577254was found to consist of 87% of themajor geometry 8a and 13% of the
other epimer (ep-8a).
Our initial attempt with 10 mol % of catalyst 8a gave a 74% ee in
enantioselective hydrosilylations of ketimine 13 (R1¼Ph, R2¼Ph,
R3¼Me) with HSiCl3 at 0 C in CH2Cl2. We then investigated the
effects of temperature (from 20e40 C) and solvent (CH2Cl2,
CHCl3 or toluene) on the enantioselectivity. The optimized reaction
condition was found to be 20 mol % of 8 in CHCl3 at room tem-
perature for 4 h (Table 1, entry 1). Finally, we examined a series of
ketimines and the results are summarized in Table 1. All substrates
were converted to the corresponding amines in high yields (94%)
and good ee% values (up to 96%). The N-(1-phenylethyl)aniline has
an OR of 13.5 in CH3OH.
The effect of different moiety of the catalyst on the hydro-
silylationwas investigated. The loss of the freeeOH (e.g., ligand 8b)
led to a decrease in ee% from 93% to 30%. Once the eO on N was
removed, as in 11a, the ee% decreased to 7%. If the asymmetric-Scheme 1. Synthesaxle-supported moiety and indol were absent as in 12, only
26% ee was achieved. The results showed that the active moiety
(NeO-containing residue) is crucial in efﬁciently catalyzing the
enantioselective hydrosilylation.3. Conclusion
In conclusion, we prepared a novel asymmetric-axle-supported
chiral NeO amide 8a as highly efﬁcient Lewis basic organocatalystis of catalyst 8.
Table 1











Entrya R1, R2, R3 Yield %b ee (%)c OR
1(a) Ph, Ph, Me 95 93 13.5
2(b) 4-FePh, Ph, Me 98 95 17.1
3(c) 4-ClePh, Ph, Me 97 94 12.1
4(d) 4-BrePh, Ph, Me 96 93 17.1
5(e) 4-F3CePh, Ph, Me 95 84 40.0
6(f) 4-NO2ePh, Ph, Me 95 78 þ16.5
7(g) 4-BrePh, PMP, Me 98 76 þ11.7
8(h) 4-MeOePh, Ph, Me 94 77 13.9
9(i) Ph, PMP, Me 97 96 2.0d
10(j) Ph, 4-EtOePh, Me 95 94 18.2
11(k) Ph, 4-MeePh, Me 95 93 þ5.7
12(l) Ph, 4-EtePh, Me 95 89 1.74
13(m) Ph, 4-BrePh, Me 98 75 þ26.6
14(n) Ph, Ph, Et 95 94 þ40
Unless speciﬁed, reactions were carried out with 2 equiv of HSiCl3 and 20% of 8a in
2 mL of CHCl3 at room temperature for 4 h.
a The bold letter in bracket represents the number for compound 14, e.g., a means
14a.
b Isolated yield.
c Determined using HPLC.
d The sign of OR was not very stable during measurement due to resolution
limitation of the polarimeter.
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pyridine compoundshas beenused in thismodel reaction for theﬁrst
time. Instead of typical low temperature, this reaction can be carried
out at room temperaturewithin only 4 h in good excellent yields and
ee values.4. Experimental section
4.1. General method
Thin layer chromatographywasperformedonTLCplates (GF254).
Flash column chromatography was performed with silica gel
(300e400 mesh). Enantiomeric excess was determined using aWa-
tersHPLCwith a 2695 pump and a 2996 diode array detector. Optical
rotations were performed on an Optical Activity AA-55 polarimeter
using a 10 cm cell with a Na 589 nm ﬁlter. IR spectra were obtained
with an FTIR spectrometer (Bruker Tensor 27). 1H NMR and 13C NMR
were recorded on a Bruker AV-400 or Bruker DRX-600 spectrometer.
Themass spectraweremeasuredonanAPIQSTARPulsar. All solvents
for the reactions were of reagent grade and were dried and distilled
before use.4.2. General procedure for preparation of catalysts
4.2.1. 9,90-Dimethyl-9H,9 0H-1,10-bipyrido[3,4-b]indole-3,30-di-
carboxylic acid (10). To a solution of 9 (5 mmol in CH3OH (40 mL))
NaOH (4 mL, 5 mol/L) was added at 0 C, the mixture was heated to
60 C, and reﬂuxed for 12 h, then HCl solution (1 M) was added to
adjust its pH to 3e4. The precipitate was ﬁltered, and washed with
water, then dried in vacuum oven. Light yellow powder 10 was ob-
tained. MS-ESI,m/z 473 [MþNa]þ. HRMSm/z calcd for C26H18N4O4Na
[MþNa]þ 473.1225, found 473.1230.1HNMR (400MHz, DMSO) d 3.47
(3H2, s, NCH3), 7.42 (1H2, t, J¼7.4 Hz), 7.66e7.78 (2H2, m), 8.58
(1H2, d, J¼7.9 Hz), 9.16 (1H2, s). 13C NMR (100MHz, DMSO) d 32.6,110.8, 117.4, 120.7, 120.8, 122.3, 129.2, 129.8, 136.3, 136.7, 139.6, 142.6,
166.8.
4.2.2. N,N0-Bis(1R,2S-2-hydroxy-1,2-diphenylethyl) 9,90-dimethyl-
9H,90H-1,10-bipyrido[3,4-b]indole-3,30-dicarboxamide (11a). To a so-
lution of 10 and 1-hydroxybenzotriazole (HOBT, 2.2 equiv) in DMF
kept under nitrogen at 0 C, DMF solution of 1-[3-(dimethylamino)
propyl]-3-ethylcarbodiimine hydrochloride (EDC, 2.2 equiv) was
added, stirred for 0.5 h, then (1S,2R)-(þ)-2-amino-1,2-diphen
ylethanol was added. The mixture solution was warmed to room
temperature and stirred overnight. After quenched with ice water,
the precipitate was ﬁltered, washed with water, and then dried in
oven. Light yellow powder 11awas obtained. [a]D11 þ189.47 (c 0.38,
CHCl3), MS-ESI, m/z 863 [MþNa]þ. HRMS-EI m/z, calcd for
C54H44N6O4 [M]þ 840.3432, found 840.3438. 1H NMR (600 MHz,
CDCl3) d 9.02 (s, 1H, NH), 8.95 (s, 1H, NH), 8.66 (d, J¼7.5 Hz,1H), 8.32
(d, J¼7.9 Hz, 1H), 8.18 (d, J¼7.9 Hz, 1H), 7.70 (t, J¼7.6 Hz, 1H), 7.64 (t,
J¼7.6 Hz,1H), 7.49e7.38 (m, 2H), 7.30 (t, J¼7.5 Hz,1H), 7.18e7.06 (m,
8H), 7.03e6.95 (m, 6H), 6.86 (dt, J¼15.3, 9.3 Hz, 6H), 6.73 (d,
J¼6.9 Hz, 2H), 5.56 (dd, J¼7.6, 5.0 Hz, 1H, PhCHOH), 5.48e5.37 (m,
1H, PhCHOH), 5.06 (d, J¼4.9 Hz, 1H, PhCHN), 4.96 (s, 1H, PhCHN),
3.28 (s, 3H, NCH3), 3.26 (s, 3H, NCH3)/13C NMR (150 MHz, CDCl3)
d 165.28, 164.67, 143.11, 143.08, 139.88, 139.48, 138.23, 138.06,
137.81, 137.49, 137.29, 137.20, 131.29, 129.56, 129.44, 128.33, 128.12,
127.83, 127.79, 127.70, 127.58, 127.29, 127.25, 126.88, 126.21, 122.23,
122.21, 121.33, 121.29, 121.15, 121.02, 115.09, 114.88, 110.06, 110.03,
79.50, 77.51, 77.32, 77.11, 76.89, 75.71, 59.91, 59.65, 32.85, 32.57.
4.2.3. N,N0-Bis(1R,2S-2-acetoxyl-1,2-diphenylethyl) 9,90-dimethyl-
9H,90H-1,10-bipyrido[3,4-b]indole-3,30-dicarboxamide (11b). To a so-
lution of 11a in DCM, 1.2 equiv acetic anhydride and 5 mol % DMAP
were added then stirred at room temperature for 3 h, after wash with
water, and puriﬁcation through silicon gel, it can gives 11b. [a]D11þ167.1
(c 0.07, CHCl3). MS-ESI, m/z 947 [MþNa]þ. HRMS-EI m/z calcd for
C58H48N6O6 [M]þ924.3635, found924.3652.1HNMR(400MHz,CDCl3)
d 9.12 (s, 1H, NH), 9.09 (s, 1H, NH), 8.76 (d, J¼9.2 Hz, 1H), 8.60 (d,
J¼9.1 Hz, 1H), 8.37 (t, J¼7.7 Hz, 2H), 7.74 (t, J¼7.7 Hz, 2H), 7.55 (d,
J¼8.4Hz,1H), 7.45 (dt, J¼23.4, 8.1Hz, 3H), 7.28 (d, J¼1.8Hz, 2H), 7.20 (s,
6H), 7.15e7.11 (m, 2H), 7.01e6.91 (m, 6H), 6.80 (t, J¼7.7 Hz, 2H), 6.67 (t,
J¼7.6 Hz, 1H), 6.56 (t, J¼7.4 Hz, 1H), 6.15 (dd, J¼11.2, 5.0 Hz, 1H2,
PhCHOH), 5.76 (dt, J¼8.9, 6.4Hz,1H2, PhCHN), 3.35 (s, 3H,NCH3), 3.30
(s, 3H, NCH3), 1.91 (s, 3H, COCH3), 1.79 (s, 3H, COCH3). 13C NMR
(101MHz,CDCl3) d169.92,169.55,164.33,164.23,143.13,143.03,138.27,
138.24, 138.16, 138.10, 137.79, 137.14, 137.12, 135.91, 134.82, 131.55,
131.23, 129.53, 129.36, 128.32, 128.24, 128.19, 128.05, 127.97, 127.61,
127.19, 126.98, 122.13, 122.06, 121.45, 121.31, 121.14, 114.91, 114.61,
110.07, 110.02, 77.62, 77.21, 56.48, 56.45, 32.72, 32.61, 20.93, 20.68.
4.2.4. 3,30-Bis[(1R,2S-2-hydroxy-1,2-diphenylethyl)aminocarbonyl]-
9 ,9 0-dimethyl -9H,9 0H-1,1 0-bipyr ido[3 ,4-b] indole-2-ox ide
(8a). Peroxide-urea (8 equiv) and TFA (8 equiv) were added to the
solution of 11a, and stirred at room temperature for 48 h. After
puriﬁed by silicon column and Chiralpak IC column, yellow powder
8a was obtained. [a]D11 211.05 (c 0.16, CHCl3). MS-ESI, m/z 879
[MþNa]þ. HRMS-EIm/z calcd for C54H44N6O5 [M]þ, 856.3373, found
856.3401. 1H NMR (600 MHz, CDCl3) d 9.08 (s, 1H, NH), 8.91 (s, 1H,
NH), 8.35 (d, J¼7.6 Hz, 1H), 7.86 (d, J¼7.3 Hz, 1H), 7.70 (dt, J¼14.4,
7.4 Hz, 2H), 7.53 (d, J¼8.3 Hz, 1H), 7.50e7.43 (m, 2H), 7.15 (dt,
J¼22.9, 7.3 Hz, 8H), 7.04 (d, J¼7.3 Hz, 2H), 6.98 (d, J¼6.9 Hz, 6H),
6.92 (d, J¼6.6 Hz, 4H), 6.68 (d, J¼3.3 Hz, 2H), 6.37 (d, J¼55.1 Hz, 1H),
5.47 (s, 1H, PhCHOH), 5.37 (d, J¼6.4 Hz, 1H, PhCHOH), 5.18 (d,
J¼6.4 Hz, 1H, PhCHN), 4.49 (s, 1H, PhCHN), 3.64 (s, 3H, NCH3), 3.08
(s, 3H, NCH3). 13C NMR (151 MHz, CDCl3) d 164.48, 160.56, 144.23,
142.95, 140.35, 140.27, 139.11, 138.78, 138.16, 138.14, 136.00, 132.77,
131.69, 131.04, 130.46, 129.79, 129.51, 128.68, 128.39, 127.87, 127.71,
127.62, 127.38, 127.20, 127.06, 126.40, 126.18, 123.12, 122.84, 122.37,
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74.56, 60.67, 60.45, 32.03, 29.86.
4.2.5. 3,30-Bis[(1R,2S-2-acetoxyl-1,2-diphenylethyl)aminocarbonyl]-
9 ,9 0-d imethyl -9H,9 0H-1,1 0-b ipyr ido[3 ,4-b] indole-2-ox ide
(8b). Following procedure to give 8a, starting from 11b, light yellow
powder 8b was obtained. MS-ESI, m/z 963 [MþNa]þ. HRMS-EI m/z
calcd for C58H48N6O7 [M]þ 940.3584, found 940.3519. [a]D11 þ405.56
(c 0.36, CHCl3). 1H NMR (600 MHz, CDCl3) d 9.30 (s, 1H, NH), 9.08 (s,
1H, NH), 8.44 (d, J¼9.1 Hz, 1H), 8.32 (d, J¼7.9 Hz, 1H), 8.26 (d,
J¼7.9 Hz, 1H), 7.74 (t, J¼7.7 Hz, 1H), 7.68 (t, J¼7.7 Hz, 1H), 7.55 (t,
J¼7.1 Hz, 1H), 7.45 (qd, J¼12.6, 8.7 Hz, 4H), 7.24e7.15 (m, 16H), 6.97
(d, J¼7.4 Hz, 3H), 6.92 (t, J¼7.4 Hz, 1H), 6.75 (t, J¼7.7 Hz, 2H), 6.22 (t,
J¼7.0 Hz, 1H, PhCHOH), 6.11 (d, J¼6.1 Hz, 1H, PhCHOH), 5.72 (td,
J¼9.3, 6.5 Hz, 2H, PhCHN), 3.53 (s, 3H, NCH3), 2.95 (s, 3H, NCH3), 1.88
(s, 3H, COCH3), 1.78 (s, 3H, COCH3). 13C NMR (151 MHz, CDCl3)
d 169.87, 169.59, 163.92, 160.19, 144.01, 142.83, 138.68, 138.62, 137.84,
137.74, 137.32, 137.05, 136.09, 132.19, 131.81, 130.81, 130.08, 129.74,
129.29, 128.25, 128.19, 128.14, 127.98, 127.72, 127.33, 127.05, 122.91,
122.33, 122.24, 121.74, 121.29, 121.27, 121.15, 120.18, 116.26, 109.99,
109.83, 77.07, 76.85, 57.79, 56.55, 31.88, 29.75, 20.95, 20.79.
4.2.6. 2-[(1R,2S-2-Hydroxy-1,2-diphenylethyl)aminocarbonyl]pyridine
oxide (12). To a solution of picolinic acid and 1-hydroxybenzotriazole
(HOBT 1.1 equiv) in DMF kept under nitrogen at 0 C, DMF solution of
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimine hydrochloride
(EDC$HCl, 1.1 equiv) was added, stirred for 0.5 h, then (1S,2R)-(þ)-2-
amino-1,2-diphenylethanol was added. The mixture was warmed to
room temperature and overnight, then quenchedwith ice water. The
precipitate was ﬁltered, and washed with water. Dried in vacuum
oven. Light yellow powder can be obtained. The powder was dis-
solved in DCM, 8 equiv peroxide-urea, and 8 equiv TFA were added
and stirred at room temperature for 48 h. After silicon column
chromatography, 12 was obtained. [a]D11 þ52.63 (c 0.19, CHCl3) MS-
ESI, m/z 357 [MþNa]þ. HRMS-EI m/z calcd for C20H18N2O3 [M]þ
334.1317, found 334.1312. 1H NMR (600 MHz, CDCl3), 8.35e8.36 (d,
J¼2.1 Hz, 1H), 8.23e8.20 (m, 1H), 7.45e7.40 (m, 1H), 7.38e7.34 (m,
1H), 7.26e7.20 (m, 7H), 7.17e7.14 (m, 2H), 7.14e7.10 (m, 2H), 5.48 (dd,
J¼8.1, 4.9 Hz, 1H), 5.14 (d, J¼4.8 Hz, 1H). 13C NMR (151 MHz, CDCl3)
d 159.56,140.73,140.64,140.04,137.27,129.19,128.42,128.28,128.23,
128.10, 127.92, 127.73, 127.61, 126.94, 77.18, 60.57.
4.3. General procedure for preparation of imines
A mixture of NaHCO3 (50 mmol), and the corresponding amine
(10 mmol) and ketone (10 mmol) plus activated molecular 4A sieves
(8.0g) inanhydrous toluene (10mL)washeatedat80 C for12hunder
an argon atmosphere. The mixture was ﬁltered through Celite. The
ﬁltrate was then evaporated in vacuum and the product was crystal-
lized from appropriate solvents or puriﬁed by distillation to give pure
imine. Only the 1H NMR data of two new imines were listed here.
4.3.1. Compound 13j. MS-ESI, m/z 240 [MþH]þ 1H NMR (400 MHz,
CDCl3) d 8.02e7.94 (m, 2H), 7.45 (dd, J¼5.2, 1.9 Hz, 3H), 6.96e6.89
(m, 2H), 6.76 (dd, J¼6.6, 2.2 Hz, 2H), 4.04 (q, J¼7.0 Hz, 2H), 2.26 (s,
3H), 1.44 (t, J¼7.0 Hz, 3H).
4.3.2. Compound 13l. MS-ESI,m/z 224 [MþH]þ 1H NMR (400 MHz,
CDCl3) d 8.02 (m, 2H), 7.51 (dd, J¼8.0, 2.3 Hz, 3H), 7.05 (d, J¼8.1 Hz,
2H), 6.67 (d, J¼8.2 Hz, 2H), 2.63 (m, 2H), 2.29 (s, 3H), 1.26 (t,
J¼7.6 Hz, 3H).
4.4. General procedure for the hydrosilylation of ketimines
Under an argon atmosphere, 2 equiv trichlorosilane was added
dropwise to a stirred solution of imine 13 and catalyst 8a (20mol %)in anhydrous CHCl3 at 27 C. The mixture was allowed to stir at the
same temperature for 4 h. The reaction was quenched with satu-
rated aqueous solution of NaHCO3 and was extracted with CH2Cl2.
The combined organic layers were washed with brine and dried
over anhydrous MgSO4 and the solvents were evaporated. Puriﬁ-
cation by column chromatography (silica gel, hexane/EtOAc)
afforded pure amine 14. The ee% values were determined using
established HPLC techniques with chiral stationary phases.
4.4.1. N-Phenyl-N-(1-phenylethyl)amine (14a). 1H NMR (400 MHz,
CDCl3) d 7.45e7.28 (m, 17H), 7.22 (dd, J¼29.8, 22.9 Hz, 7H), 7.10 (d,
J¼7.4 Hz, 6H), 6.68 (t, J¼7.3 Hz, 4H), 6.55 (d, J¼7.8 Hz, 8H), 4.50 (q,
J¼6.7 Hz, 5H), 1.54 (d, J¼6.7 Hz, 13H). Enantiomeric excess was
determined by HPLC with a chiralcel OD-H column (hexane/2-
propanol¼98/2, 1 mL/min), tminor¼10.7 min; tmajor¼12.9 min, 93%
ee. [a]D14 13.5 (c 0.85, CH3OH).
4.4.2. N-Phenyl-N-[1-(4-ﬂuorophenyl)ethyl]amine (14b). 1H NMR
(400 MHz, CDCl3) d 7.45e7.26 (m, 2H), 7.15e6.90 (m, 4H), 6.71 (t,
J¼7.3 Hz,1H), 6.55 (d, J¼7.8 Hz, 2H), 4.47 (dd, J¼13.4, 6.6 Hz,1H),1.53
(d, J¼6.7 Hz, 3H). Enantiomeric excess was determined by HPLC with
a chiralcel OD-H column (hexane/2-propanol¼98/2, 0.5 mL/min),
tminor¼19.9min; tmajor¼22.7min, 95%ee. [a]D1417.1 (c0.002, CH3OH).
4.4.3. N-Phenyl-N-[1-(4-chlorophenyl)ethyl]amine (14c). 1H NMR
(400MHz, CDCl3) d 7.45e7.28 (m,17H), 7.22 (dd, J¼29.8, 22.9 Hz, 7H),
7.10 (d, J¼7.4Hz, 6H), 6.68 (t, J¼7.3Hz, 4H), 6.55 (d, J¼7.8Hz, 8H), 4.50
(q, J¼6.7 Hz, 5H), 1.54 (d, J¼6.7 Hz, 13H). Enantiomeric excess was
determined by HPLC with a chiralcel OD-H column (hexane/2-
propanol¼98/2, 0.5 mL/min), tminor¼26.3 min; tmajor¼29.6 min, 94%
ee. [a]D14 12.1 (c 0.03, CH3OH).
4.4.4. N-Phenyl-N-[1-(4-bromophenyl)ethyl)amine] (14d). 1H NMR
(400MHz, CDCl3) d 7.34 (d, J¼8.4 Hz, 2H), 7.16 (d, J¼8.2 Hz, 2H), 7.01
(t, J¼7.9 Hz, 2H), 6.59 (t, J¼7.3 Hz, 1H), 6.40 (d, J¼7.7 Hz, 2H), 4.34
(dd, J¼13.4, 6.7 Hz, 1H), 1.41 (d, J¼6.7 Hz, 3H). Enantiomeric excess
was determined by HPLC with a chiralcel OD-H column (hexane/2-
propanol¼95/5, 1 mL/min), tminor¼10.7 min; tmajor¼12.1 min, 90%
ee. [a]D14 17.1 (c 0.02, CH3OH).
4.4.5. N-Phenyl-N-[1-(4-triﬂuoromethylphenyl)ethyl]amine
(14e). 1H NMR (400 MHz, CDCl3) d 7.58 (s, 6H), 7.53 (dd, J¼29.2,
8.1 Hz, 29H), 7.28 (s, 2H), 7.15 (dd, J¼37.7, 29.8 Hz, 26H), 6.72 (t,
J¼7.3 Hz, 9H), 6.54 (d, J¼7.6 Hz, 16H), 4.53 (dd, J¼13.4, 6.7 Hz, 12H),
1.56 (d, J¼6.7Hz, 35H). Enantiomeric excesswas determined byHPLC
with a chiralcelOD-Hcolumn (hexane/2-propanol¼90/10,1mL/min),
tminor¼8.7 min; tmajor¼9.8 min, 84% ee. [a]D14 40 (c 0.015, CH3OH).
4.4.6. N-Phenyl-N-[1-(4-nitrophenyl)ethyl)amine] (14f). 1H NMR
(400 MHz, CDCl3) d 8.18 (d, J¼8.7 Hz, 4H), 7.56 (d, J¼8.6 Hz, 4H), 7.11
(dd, J¼8.5, 7.4Hz, 4H), 6.71 (t, J¼7.3Hz,2H), 6.48 (d, J¼7.7Hz, 4H), 4.57
(dd, J¼13.5, 6.8 Hz, 3H), 1.56 (d, J¼6.8 Hz, 6H). Enantiomeric excess
was determined by HPLC with a chiralcel OD-H column (hexane/2-
propanol¼98/2, 0.5 mL/min), tminor¼20.4 min; tmajor¼22.1 min, 78%
ee. [a]D14 þ16.5 (c 0.03, CH3OH).
4.4.7. N-Methoxyphenyl-N-[1-(4-bromophenyl)ethyl]amine
(14g). 1H NMR (400 MHz, CDCl3) d 7.42 (d, J¼8.4 Hz, 2H), 7.25 (d,
J¼9.2 Hz, 2H), 6.74e6.66 (m, 2H), 6.50 (d, J¼8.7 Hz, 2H), 4.36 (dd,
J¼13.2, 6.6 Hz, 1H), 3.69 (d, J¼6.0 Hz, 3H), 1.51 (d, J¼6.7 Hz, 3H).
Enantiomeric excess was determined by HPLC with a chiralcel OD-
H column (hexane/2-propanol¼98/2, 1 mL/min), tmajor¼19.8 min;
tminor¼26.2 min, 80% ee. [a]D14 þ11.69 (c 0.03, CH3OH).
4.4.8. N-Phenyl-N-[1-(4-methoxyphenyl)ethyl]amine (14h). 1H NMR
(400MHz, CDCl3) d7.30 (t, J¼12.4Hz, 2H), 7.17e6.99 (m,2H), 6.99e6.79
W. Pan et al. / Tetrahedron 69 (2013) 7253e7257 7257(m, 2H), 6.73e6.46 (m, 3H), 4.47 (q, J¼6.7 Hz, 1H), 3.79 (s, 3H), 1.52 (d,
J¼6.7 Hz, 3H). Enantiomeric excess was determined by HPLC with
a chiralcel OD-H column (hexane/2-propanol¼98/2, 1 mL/min), tmi-
nor¼13.2 min; tmajor¼14.1 min, 79% ee. [a]D14 13.93 (c 0.01, CH3OH).
4.4.9. N-Methoxyphenyl-N-[(1-phenyl)ethyl]amine (14i). 1H NMR
(400 MHz, CDCl3) d 7.57e7.28 (m, 4H), 7.31e7.14 (m, 1H), 6.82e6.66
(m,2H), 6.51 (d, J¼8.9Hz, 2H), 4.44 (dd, J¼13.3,6.6Hz,1H), 3.72 (s, 3H),
1.53 (d, J¼6.7 Hz, 3H). Enantiomeric excess was determined by HPLC
with a chiralcel AD-H column (hexane/2-propanol¼98/2, 1 mL/min),
tmajor¼10.7min; tminor¼12.3min, 96%ee. [a]D142.03 (c0.013, CH3OH).
4.4.10. N-Ethoxyl-N-[(1-phenyl)ethyl]amine (14j). MS-ESI, m/z 242
[MþH]þ. 1H NMR (400 MHz, CDCl3) d 7.56e7.10 (m, 5H), 6.92e6.58
(m, 2H), 6.51 (d, J¼8.6 Hz, 2H), 4.42 (dd, J¼13.2, 6.6 Hz, 1H), 3.91
(dd, J¼13.9, 7.0 Hz, 2H), 1.53 (d, J¼6.7 Hz, 3H), 1.34 (t, J¼7.0 Hz, 3H).
Enantiomeric excess was determined by HPLC with a chiralcel AD-
H column (hexane/2-propanol¼98/2, 1 mL/min), tmajor¼9.9 min;
tminor¼11.5 min, 92% ee. [a]D14 18.2 (c 0.015, CH3OH).
4.4.11. N-Methylphenyl-N-[(1-lphenyl)ethyl]amine (14k). 1H NMR
(400 MHz, CDCl3) d 7.46e7.30 (m, 4H), 7.25 (s, 1H), 6.93 (d, J¼8.1 Hz,
2H), 6.48 (d, J¼8.4 Hz, 2H), 4.48 (q, J¼6.7 Hz,1H), 2.22 (s, 3H),1.54 (d,
J¼6.7 Hz, 3H). Enantiomeric excess was determined by HPLC with
a chiralcel OD-H column (hexane/2-propanol¼99/1, 1 mL/min), tma-
jor¼11.3 min; tminor¼13.1 min, 93% ee. [a]D14 þ3.6 (c 0.025, CH3OH).
4.4.12. N-Ethylphenyl-N-[(1-phenyl)ethyl]amine (l4l). MS-ESI, m/z
226 [MþH]þ. 1H NMR (400 MHz, CDCl3) d 7.60e7.09 (m, 5H), 6.95
(d, J¼8.0 Hz, 2H), 6.51 (d, J¼8.0 Hz, 2H), 4.47 (dd, J¼12.9, 6.3 Hz,1H),
2.51 (dd, J¼14.9, 7.4 Hz, 2H), 1.54 (d, J¼6.6 Hz, 3H), 1.16 (t, J¼7.5 Hz,
3H). Enantiomeric excess was determined by HPLC with a chiralcel
OD-H column (hexane/2-propanol¼97/3þ0.1% Et3N, 1 mL/min),
tmajor¼8.2min; tminor¼8.8min, 93% ee. [a]D141.74 (c 0.025, CH3OH).
4.4.13. N-4-Bromophenyl-N-[(1-phenyl)ethyl]amine (14m). 1H NMR
(400 MHz, CDCl3) d 7.41e7.29 (m, 4H), 7.29e7.22 (m, 1H), 7.16 (d,
J¼8.8 Hz, 2H), 6.40 (d, J¼8.8 Hz, 2H), 4.44 (q, J¼6.7 Hz, 1H), 1.53 (d,
J¼6.7 Hz, 3H). Enantiomeric excess was determined by HPLC with
a chiralcel OD-H column (hexane/2-propanol¼99/1, 1 mL/min), tma-
jor¼15.3 min; tminor¼20.5 min, 76% ee. [a]D14 26.6 (c 0.008, CH3OH).
4.4.14. N-phenyl-N-(1-lphenylpropyl)amine (14n). 1H NMR (400 MH
z, CDCl3) d 7.54e7.17 (m, 5H), 7.09 (t, J¼7.3 Hz, 2H), 6.64 (dd, J¼41.1,
6.7 Hz, 3H), 4.22 (t, J¼6.4 Hz, 1H), 1.88 (dd, J¼13.1, 6.5 Hz, 2H), 0.92
(dd, J¼19.6, 12.4 Hz, 3H). Enantiomeric excess was determined by
HPLC with a chiralcel AD-H column (hexane/2-propanol¼98/2,1 mL/min), tminor¼13.0 min; tmajor¼15.2 min, 94% ee. [a]D14 þ40 (c
0.01, CH3OH).
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